Clinical Trials Browser

EGF-R Positive Non-Small Cell Lung Cancer × aflutinib × Clear all

NCT06352502 2024-04-08

An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis

EGF-R Positive Non-Small Cell Lung Cancer